Evidence map›Paper›PMID 29162120›Full record

Trial reportMalaria journal2017

A village level cluster-randomized entomological evaluation of combination long-lasting insecticidal nets containing pyrethroid plus PBO synergist in Southern Mali.

Moussa B M Cisse, Djibril Sangare, Richard M Oxborough, Abdourhamane Dicko, Dereje Dengela, Aboubacar Sadou, Jules Mihigo, Kristen George, Laura Norris, Christen Fornadel

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Moussa B M CisseUniversité des Sciences Techniques et Technologiques de Bamako (USTTB), Bamako, Mali.
Djibril SangareUniversité des Sciences Techniques et Technologiques de Bamako (USTTB), Bamako, Mali.
Richard M OxboroughPMI Africa Indoor Residual Spraying Project, Abt Associates 4550 Montgomery Ave, Suite 800 North, Bethesda, MD, 20814, USA. Richard_Oxborough@abtassoc.com.
Abdourhamane DickoProgramme National de Lutte Contre le Paludisme (PNLP), Ministère de la Santé, Bamako, Mali.
Dereje DengelaPMI Africa Indoor Residual Spraying Project, Abt Associates 4550 Montgomery Ave, Suite 800 North, Bethesda, MD, 20814, USA.
Aboubacar SadouPresident's Malaria Initiative USAID, ACI2000; Rue 243, Porte 297, BP 34, Bamako, Mali.
Jules MihigoPresident's Malaria Initiative USAID, ACI2000; Rue 243, Porte 297, BP 34, Bamako, Mali.
Kristen GeorgePresident's Malaria Initiative USAID, 1300 Pennsylvania Avenue NW, Washington, DC, USA.
Laura NorrisPresident's Malaria Initiative USAID, 1300 Pennsylvania Avenue NW, Washington, DC, USA.
Christen FornadelPresident's Malaria Initiative USAID, 1300 Pennsylvania Avenue NW, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is growing concern that malaria vector resistance to pyrethroid insecticides may reduce the effectiveness of long-lasting insecticidal nets (LLINs). Combination LLINs are designed to control susceptible and pyrethroid-resistant mosquito populations through a mixture of pyrethroid with piperonyl butoxide (PBO) synergist. A cluster randomized trial with entomology outcome measures was conducted in Mali to determine the added benefit over mono-treated pyrethroid predecessors. Four LLIN treatments; permethrin + PBO, permethrin, deltamethrin + PBO, and deltamethrin, were randomly allocated to four villages each (16 villages total) and distributed to cover every sleeping place. Entomological monitoring of indoor Anopheles resting densities, host preference, vector longevity, and sporozoite rates were monitored every 2 months over 2 years in 2014 and 2015.

resultsBottle bioassays confirmed permethrin and deltamethrin resistance in Anopheles gambiae sensu lato (s.l.), (the predominant species throughout the study) with pre-exposure to PBO indicating partial involvement of oxidases. Between 2014 and 2015 the mean indoor resting density was greater in the deltamethrin + PBO LLIN arm than the deltamethrin LLIN arm at 3.05 (95% CI 3.00-3.10) An. gambiae s.l. per room per day compared with 1.9 (95% CI 1.87-1.97). There was no significant difference in sporozoite rate at 3.97% (95% CI 2.91-5.02) for the deltamethrin LLIN arm and 3.04% (95% CI 2.21-3.87) for deltamethrin + PBO LLIN arm (P = 0.17). However, when analysed by season there was some evidence that the sporozoite rate was lower in the deltamethrin + PBO LLIN arm than deltamethrin LLIN arm during the rainy/high malaria transmission seasons at 1.95% (95% CI 1.18-2.72) and 3.70% (95% CI 2.56-4.84) respectively (P = 0.01).

conclusionsWhile there was some evidence that An. gambiae s.l. sporozoite rates were lower in villages with deltamethrin + PBO LLINs during the high malaria transmission seasons of 2014-2015, there was no reduction in parity rates or indoor resting densities. There was also no evidence that permethrin + PBO LLINs provided any improved control when compared with permethrin LLINs. Combination nets may have a greater impact in areas where mixed function oxidases play a more important role in pyrethroid resistance.

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsMosquito ControlMosquito VectorsAnimalsCluster AnalysisDrug SynergismLongevityMaliNitrilesPermethrinPiperonyl ButoxidePyrethrinsRural PopulationdecamethrinInsecticidesNitrilesPermethrinPiperonyl ButoxidePyrethrinsAnopheles gambiaeCombination netsLLINMaliMFOsOlyset PlusPBOPermanet 3.0Pyrethroid resistance

Identifiers

PMID29162120
PMCPMC5698970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.